Tarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $50.40, gaining 10.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Foreign Jack Tars presents the first in-depth study of their employment in the Navy during this crucial period. Based on sources from across Britain, Europe, and the US, and blending quantitative, ...
The market expects Tarsus Pharmaceuticals, Inc. (TARS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely ...